Dr. Cohen is the chief of the division of gastroenterology and hepatology at the Weill department of medicine. He is a member of the American Society for Clinical Investigation and is a physician scientist who focuses on the molecular regulation of glucose and hepatic lipid metabolism.
Through his research at the Cohen Laboratory, Dr. Cohen discovered small molecular inhibitors of phosphatidylcohline transfer protein, demonstrating how they could increase hepatic insulin sensitivity.
In 2016, he became the editor of Hepatology.
More articles on gastroenterology:
Cantel Medical taps Bill Haydon as new SVP, general manager of medical division
Texas gastroenterologist killed in car crash
GI leader to know: Dr. Philip Styne of Florida Hospital
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
